About 3 results found for searched term "DRAK2-IN-1" (0.257 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M28728 | DRAK1/2-IN-1 | Apoptosis |
| DRAK1/2-IN-1 (compound 10e) is an active dual DRAK1 and DRAK2 inhibitor with Kd values of 1 μM and 6 μM, respectively. | ||
| M49489 | DRAK2-IN-1 | DAPK |
| DRAK2-IN-1 is a potent, selective, ATP-competitive DRAK2 inhibitor with IC50 and Ki values of 3 nM and 0.26 nM, respectively.In addition, DRAK2-IN-1 also inhibits DRAK1 (IC50=51 nM). | ||
| M24614 | Tildrakizumab | IL Receptor/Related |
| SCH 900222; MK 3222; Anti-Human IL23 Recombinant Antibody | ||
| Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
